Match!
Andreas Kocjan
Placebo-controlled studyPlaceboUlcerative colitisGeneral surgeryMedicine
3Publications
2H-index
54Citations
What is this?
Publications 3
Newest
OBJECTIVES: Phosphatidylcholine is a key component of the mucosal barrier. Treatment with modified release phosphatidylcholine aims to improve the impaired barrier function. The primary objective is to evaluate the efficacy of LT-02, a newly designed modified release phosphatidylcholine formula, in a multicenter setting. METHODS: This is a double-blinded, randomized, placebo-controlled, superiority study conducted in 24 ambulatory referral centers in Germany, Lithuania, and Romania. A total of 1...
51 CitationsSource
#1Max KarnerH-Index: 10
#2Andreas KocjanH-Index: 2
Last. Wolfgang StremmelH-Index: 75
view all 14 authors...
Source
#1Max KarnerH-Index: 10
#2Andreas KocjanH-Index: 2
Last. Wolfgang StremmelH-Index: 75
view all 12 authors...
3 CitationsSource
1